Ground News

News from Lupin

See all of Lupin news coverage in one place. Discover how Lupin’s media bias informs their coverage and compare with thousands of other news outlets.

In total, 29 have been published by Lupin which Ground News has aggregated in the past 3 months.

Lupin’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

We’ve assigned a rating of Unknown factuality to Lupin. You can read more about how we’ve determined Lupin’s credibility and reliability as a news source here: https://groundnews.lakegeneva.lib.wi.us/rating-system.

Information about Lupin

Where is Lupin located?Lupin's Website Lupin's Twitter

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Lupin News

United Nations

Avaada Inspires Collective Climate Action on World Environment Day with 'Mission Possible'

100% Right coverage: 1 sources

Avaada Group, the clean energy company, has unveiled its flagship environmental initiative, Mission Possible with Avaada, on the occasion of World Environment Day. This month-long campaign, aimed at igniting awareness and ownership of our planet’s future, concludes with a stirring film that calls for meaningful, collective action—from individuals to institutions. Conceived by Vineet Mittal, Chairman […] The post Avaada inspires collective climat…See the Story

Palghar · Palghar

Lupin Foundation Flags off Mobile Medical Van in Palghar to Strengthen Non-Communicable Disease Care

Read Article

United States · United States

Lupin Receives Tentative Approval from U.S. FDA for Oxcarbazepine ER Tablets

Read Article

Lupin won the Champions for Excellence award in Transfer Pricing at the 11th Edition of Tax Strategy & Planning Summit & Awards 2025, organized by the UBS Forums.

Read Article

International Day of Action for Women's Health: A Day for Her Health

100% Left coverage: 1 sources

Last Updated on May 28, 2025 by Tanya Every year, on May 28, the world observes International Day of Action for Women’s Health to create awareness regarding the special health concerns of women throughout their lifespan. They face an array of physical, emotional, and mental health problems during adolescence, menopause, and even later life, which […] The post International Day of Action for Women’s Health: A day for her health appeared first on …Abortion See the Story

Lupin Announces Presentation of Phase 1 Data on LNP7457 (PRMT5 inhibitor) at the American Society of Clinical Oncology - Annual Meeting 2025

100% Center coverage: 1 sources

MUMBAI, India, NAPLES, Fla. and CHICAGO, May 27, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) will present data from its Phase 1a clinical trial evaluating LNP7457, a PRMT5 inhibitor, at the American Society of Clinical Oncology (ASCO) annual…Chicago, IL · Chicago See the Story

How Indian Pharma is Building a Sustainability Framework for a Greener Future

Mumbai · Mumbai Read Article

Lupin to Commercialise Ranibizumab in Latin America

Lupin has signed a licence and supply agreement with SteinCares to commercialise its biosimilar ranibizumab in Latin America.See the Story

LUPIN AND HONEYWELL MOVE FORWARD JOINTLY WITH PLANS FOR HFO TECHNOLOGY IN INHALERS

Lupin is set to become first Indian company to fully integrate Honeywell’s Solstice® Air in its respiratory inhalers at scale, redefining respiratory care with near-zero global warming potential propellants Global pharma major Lupin Limited (Lupin) announced today its plan to use Honeywell’s Solstice® Air (HFO-1234ze(E) cGMP) propellant to transform respiratory care through the development of next-generation inhalers. Designed for patients with …Pharma · India See the Story

Ramesh Swminathan with NDTV Profit, FY2025 Earnings, 15th May 2025

Mumbai · Mumbai Read Article

Lupin Receives Approval from U.S. FDA for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg

United States · United States Read Article

News from Lupin

News from Lupin

Information about Lupin

Media Bias Ratings

Factuality

Ownership

Top Lupin News

Avaada Inspires Collective Climate Action on World Environment Day with 'Mission Possible'

Lupin Foundation Flags off Mobile Medical Van in Palghar to Strengthen Non-Communicable Disease Care

Lupin Receives Tentative Approval from U.S. FDA for Oxcarbazepine ER Tablets

Lupin won the Champions for Excellence award in Transfer Pricing at the 11th Edition of Tax Strategy & Planning Summit & Awards 2025, organized by the UBS Forums.

International Day of Action for Women's Health: A Day for Her Health

Lupin Announces Presentation of Phase 1 Data on LNP7457 (PRMT5 inhibitor) at the American Society of Clinical Oncology - Annual Meeting 2025

How Indian Pharma is Building a Sustainability Framework for a Greener Future

Lupin to Commercialise Ranibizumab in Latin America

LUPIN AND HONEYWELL MOVE FORWARD JOINTLY WITH PLANS FOR HFO TECHNOLOGY IN INHALERS

Ramesh Swminathan with NDTV Profit, FY2025 Earnings, 15th May 2025

Lupin Receives Approval from U.S. FDA for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg

Similar News Topics

Topics Most Covered by Lupin

Sources Covering Similar Topics

Breaking News Topics Related to Lupin